Teladoc Health Inc (NYSE: TDOC) started the day on Wednesday, with a price decrease of -5.44% at $6.61, before settling in for the price of $6.99 at the close. Taking a more long-term approach, TDOC posted a 52-week range of $6.35-$15.21.
In the past 5-years timespan, the Healthcare sector firm’s annual sales growth was -33.66%. Meanwhile, its Annual Earning per share during the time was -33.66%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 79.92%. This publicly-traded company’s shares outstanding now amounts to $177.35 million, simultaneously with a float of $175.52 million. The organization now has a market capitalization sitting at $1.17 billion.
Teladoc Health Inc (TDOC) Ownership Facts and Figures
Now let’s turn our focus to how large-scale investors are working with this stock of the Health Information Services Industry. Teladoc Health Inc’s current insider ownership accounts for 1.10%, in contrast to 70.90% institutional ownership. According to the most recent insider trade that took place on Jan 05 ’26, this organization’s Chief Accounting Officer sold 758 shares at the rate of 7.14, making the entire transaction reach 5,416 in total value, affecting insider ownership by 6,686. Preceding that transaction, on Dec 11 ’25, Company’s CHIEF EXECUTIVE OFFICER sold 17,138 for 7.63, making the whole transaction’s value amount to 130,837. This particular insider is now the holder of 201,036 in total.
Teladoc Health Inc (TDOC) Earnings and Revenue Records
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.27 per share during the current fiscal year.
Teladoc Health Inc’s EPS increase for this current 12-month fiscal period is 79.92% and is forecasted to reach -0.83 in the upcoming year. Considering the longer run, market analysts have predicted that Company’s EPS will increase by 51.54% through the next 5 years, which can be compared against the -33.66% growth it accomplished over the previous five years trading on the market.
Teladoc Health Inc (NYSE: TDOC) Trading Performance Indicators
Let’s observe the current performance indicators for Teladoc Health Inc (TDOC). It’s Quick Ratio in the last reported quarter now stands at 2.52. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 0.46. Similarly, its price to free cash flow for trailing twelve months is now 4.25.
In the same vein, TDOC’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -1.28, a figure that is expected to reach -0.18 in the next quarter, and analysts are predicting that it will be -0.83 at the market close of one year from today.
